HUP0500921A2 - Tetrazole derivatives, process for their preparation and their use - Google Patents
Tetrazole derivatives, process for their preparation and their useInfo
- Publication number
- HUP0500921A2 HUP0500921A2 HU0500921A HUP0500921A HUP0500921A2 HU P0500921 A2 HUP0500921 A2 HU P0500921A2 HU 0500921 A HU0500921 A HU 0500921A HU P0500921 A HUP0500921 A HU P0500921A HU P0500921 A2 HUP0500921 A2 HU P0500921A2
- Authority
- HU
- Hungary
- Prior art keywords
- preparation
- tetrazole derivatives
- tetrazole
- derivatives
- Prior art date
Links
- 150000003536 tetrazoles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0500921A HUP0500921A2 (en) | 2005-10-05 | 2005-10-05 | Tetrazole derivatives, process for their preparation and their use |
PCT/HU2006/000088 WO2007039782A1 (en) | 2005-10-05 | 2006-10-05 | Tetrazole derivatives as modulators of metabotropic glutamate receptors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0500921A HUP0500921A2 (en) | 2005-10-05 | 2005-10-05 | Tetrazole derivatives, process for their preparation and their use |
Publications (2)
Publication Number | Publication Date |
---|---|
HU0500921D0 HU0500921D0 (en) | 2005-12-28 |
HUP0500921A2 true HUP0500921A2 (en) | 2007-07-30 |
Family
ID=89986318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0500921A HUP0500921A2 (en) | 2005-10-05 | 2005-10-05 | Tetrazole derivatives, process for their preparation and their use |
Country Status (2)
Country | Link |
---|---|
HU (1) | HUP0500921A2 (en) |
WO (1) | WO2007039782A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200811137A (en) * | 2006-05-05 | 2008-03-01 | Astrazeneca Ab | mGluR5 modulators II |
TW200808777A (en) * | 2006-05-05 | 2008-02-16 | Astrazeneca Ab | MGLUR5 modulators III |
US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
AR080056A1 (en) | 2010-02-01 | 2012-03-07 | Novartis Ag | CICLOHEXIL-AMIDA DERIVATIVES AS ANTAGONISTS OF CRF RECEIVERS |
CN102762572A (en) | 2010-02-01 | 2012-10-31 | 诺瓦提斯公司 | Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
WO2011095450A1 (en) | 2010-02-02 | 2011-08-11 | Novartis Ag | Cyclohexyl amide derivatives as crf receptor antagonists |
HUE044447T2 (en) | 2010-09-02 | 2019-10-28 | Monsanto Technology Llc | New compositions and methods for controlling nematode pests |
KR20130132816A (en) | 2010-10-21 | 2013-12-05 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | 1-(heterocyclic carbonyl) piperidines |
BR112015021452A2 (en) | 2013-03-15 | 2017-07-18 | Monsanto Technology Llc | n-, c-disubstituted azoles to control nematode pests |
CA2972294C (en) * | 2014-12-24 | 2018-09-25 | National Institute Of Biological Sciences, Beijing | Necrosis inhibitors |
WO2017002083A1 (en) | 2015-07-02 | 2017-01-05 | Wockhardt Limited | Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60226756D1 (en) * | 2001-10-04 | 2008-07-03 | Merck & Co Inc | METABOTROPIC GLUTAMATE RECEPTOR-5 HETEROARYLSUBSTITUTED TETRAZOL MODULATORS |
MY145075A (en) * | 2004-02-18 | 2011-12-15 | Astrazeneca Ab | Tetrazole compounds and their use as metabotropic glutamate receptor antagonists. |
AU2005214378A1 (en) * | 2004-02-18 | 2005-09-01 | Astrazeneca Ab | Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists |
EP1809620B1 (en) * | 2004-11-04 | 2010-12-29 | Addex Pharma SA | Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
-
2005
- 2005-10-05 HU HU0500921A patent/HUP0500921A2/en unknown
-
2006
- 2006-10-05 WO PCT/HU2006/000088 patent/WO2007039782A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007039782A1 (en) | 2007-04-12 |
HU0500921D0 (en) | 2005-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1937766A4 (en) | Modified polyamides, uses thereof and process for their preparation | |
PL1928882T3 (en) | (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use | |
HUP0500921A2 (en) | Tetrazole derivatives, process for their preparation and their use | |
ZA200903160B (en) | Sulfonyl-Phenyl-2H-[1,2,4]Oxodiazol-5-one Derivatives, Processes for their preparation and their use as pharmaceuticals | |
ZA200805939B (en) | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
HUP0500920A2 (en) | Oxadiazole derivatives, process for their preparation and their use | |
IL220816A0 (en) | Process for preparing cell-binding agent-cytotoxic agent | |
SI1913001T1 (en) | (r)-n-methylnaltrexone, processes for its synthesis and its pharmaceutical use | |
IL193467A0 (en) | Substituted indazole derivatives, their manufacture and use as pharmaceutical agents | |
IL191655A0 (en) | Novel compounds, their preparation and use | |
IL179424A0 (en) | Substituted oxazole -benzoisothiazole dioxide derivatives, process for their preparation and their use | |
EP1922309A4 (en) | N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof | |
EP1988090A4 (en) | Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof | |
PL1874765T3 (en) | Urea derivatives, methods for their manufacture and uses thereof | |
ZA200806799B (en) | Novel pyrone-indole derivatives and process for their preparation | |
IL193339A0 (en) | Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
IL193341A0 (en) | Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments | |
EP1961753A4 (en) | Pyrazolopyrimidinone derivatives, their preparation and their use | |
TWI315305B (en) | Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof | |
SI2020410T1 (en) | PyridoŠ2,3-dĆpyrimidine derivatives, process for their preparation and their therapeutical use | |
IL184314A0 (en) | Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them | |
EP1907468A4 (en) | Process for nanocomposites preparation, and nanocomposites | |
IL190596A0 (en) | 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments | |
HK1100946A1 (en) | 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF | |
IL190334A0 (en) | Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |